Viewing Study NCT00052169


Ignite Creation Date: 2025-12-24 @ 10:57 PM
Ignite Modification Date: 2026-04-07 @ 5:54 PM
Study NCT ID: NCT00052169
Status: COMPLETED
Last Update Posted: 2007-12-18
First Post: 2003-01-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Therapy With Docetaxel and ZD1839 for Patients Who Have Advanced Breast Cancer
Sponsor: NSABP Foundation Inc
Organization:

Organization Data

Organization:
Class: NETWORK
Study ID: NSABP FB-IR-002
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: NETWORK
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: Norman Wolmark, MD/Chairman, NSABP Foundation Inc.
Old Organization: NSABP Foundation, Inc.

Collaborators

Collaborators

Name Class View
None INDUSTRY View